Introduction
D-Serine, formed by serine racemase (SR), which converts L-serine to D-serine, is a physiologic coagonist with glutamate at NMDA receptors (Wolosker, 2006) . D-Serine is primarily localized to glia that ensheathe neurons, whereas SR occurs both in glia and neurons (Wolosker, 2006) . SR is dynamically regulated by glutamate. Thus, activation of metabotropic glutamate receptors leads to cleavage of phosphatidylinositol (4,5)-bisphosphate (PIP2) by phospholipase C (PLC), thereby diminishing inhibition by PIP2 of SR . Glutamate receptor interacting protein (GRIP), normally bound to AMPA receptors, dissociates upon neuronal depolarization to bind to and activate SR . Glutamate/D-serine activation of NMDA receptors leads to formation of nitric oxide (NO), which nitrosylates and inactivates SR, providing a feedback homeostatic regulation (Mustafa et al., 2007) . D-Serine is degraded by D-amino acid oxidase, which, along with its associated protein G72, has been linked to schizophrenia (Coyle, 2006) .
To elucidate physiologic roles of D-serine, we created SRdeleted mice (Basu et al., 2009 ). The mutant mice display an 85% reduction in D-serine levels with alterations in NMDA neurotransmission and decreased long term potentiation (LTP). However, both NMDA transmission and LTP are enhanced by exogenous application of D-serine in the mutant mice, suggesting receptor supersensitivity. Male, but not female, SR knock-outs exhibit spatial memory deficits (Basu et al., 2009) . The reasons for this gender discrepancy are not entirely clear. In the present study, we have examined pathophysiologic consequences of SR deletion. We show marked diminution in neuronal death following oxygen-glucose deprivation of SR Ϫ/Ϫ brain cultures and substantially less brain damage following middle cerebral artery occlusion. These changes are accompanied by pronounced declines in NO formation and nitrosylation of its targets. SR Ϫ/Ϫ mice also display NMDA receptor supersensitivity, as evidenced by increased NR1 receptor protein levels and enhanced NMDAelicited brain damage.
Materials and Methods
Animals. Biochemical experiments involving animals were performed on brains removed from 8 -10-week-old male wild-type, SR Ϫ/Ϫ (Basu et al., 2009), and neuronal NO synthase (nNOS) Ϫ/Ϫ animals. Animals were maintained on a 12 h light/dark cycle at a room temperature of 23°C, with ad libitum access to food and water. All animal-use procedures were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Johns Hopkins University Animal Care and Use Committee.
Antibodies. Antibodies to SR and nNOS were from BD Biosciences, antibodies to NMDA receptor NR1, ␤-tubulin, and actin were from Millipore, and antibodies to GAPDH were from Calbiochem.
Oxygen-glucose deprivation. The oxygen-glucose deprivation (OGD) experiments were done as described previously (Eliasson et al., 1997) . Briefly, cortical cultures grown for 12-14 d in Neurobasal media supplemented with horse serum at 37°C were treated with 10 mM L-serine for 5 h and then exposed to a gas mixture of 5% CO 2 /95% N 2 in an airtight chamber with OGD buffer containing (in mM) 125 NaCl, 3 KCl, 1.6 CaCl 2 , 0.2 arginine, 25 HEPES, pH 7.4, 1 D-glucose, and 1.25 Na 2 HPO 4 for 1 h at 37°C. The OGD solution was then replaced with regular neuronal culture media and the cells grown for 24 h at 37°C. Toxicity was assayed by microscopic examination with computer-assisted cell counting following staining of all nuclei with 1 g/ml Hoechst 33258 stain and dead cells with 7 M propidium iodide. Total and dead cells were counted, and the percentage of cell death was determined. Experimenters were blinded.
Middle cerebral artery occlusion. All mice were 8 -10-week-old male SR Ϫ/Ϫ and matched wild-type littermates weighing between 20 and 25 g. Transient focal ischemia was induced by a 90 min occlusion of the middle cerebral artery (MCA) in wild-type and SR Ϫ/Ϫ mice, as described previously (Zeynalov and Doré, 2009) . Successful occlusion was confirmed by an 87-90% reduction in cerebral blood flow (CBF), as measured by Laser-Doppler flowmetry. After reperfusion was begun and isoflurane anesthesia was discontinued, the animals were kept in a humidified thermoregulated chamber until they became completely awake (usually within 20 -30 min). At 24 h of reperfusion, the mice were deeply anesthetized and the brains processed for analysis of infarct volume. Brains were harvested, sliced into 2-mm-thick sections and stained with 1% 2,3,5-triphenyltetrazolium chloride. Infarct volume was calculated as a percentage of the contralateral hemisphere and corrected for swelling.
NMDA excitotoxicity assays. Weight and rectal temperature of each mouse was recorded before the surgical procedure. Anesthesia was induced with 3.0% halothane and thereafter maintained at 1.0% halothane. Each mouse was mounted on a stereotaxic frame, and 0.3 l of NMDA (67 mM), prepared in PBS, was injected into the right striatum over a 2 min period; the needle was left in situ for an additional 5 min to prevent back flow. After injections, mice were placed in a humidified, thermoregulated chamber maintained at 31°C and then returned to their cages after full recovery from anesthesia. Throughout the experimental procedure, mouse rectal temperature was monitored and maintained at 37.0 Ϯ 0.5°C. Fortyeight hours after injection, brains were harvested and immediately frozen in 2-methylbutane (precooled over dry ice); 20 m sections were cut on a cryostat and stained with cresyl violet to measure lesion volume. Brain sections were photographed and analyzed with SigmaScan Pro 5.0 (Systat Software).
NO generation. NO formation was assessed in cortical neurons cultured for 12-14 d at 37°C or from 6 -8-week-old mouse brains. Cultures, treated with 10 mM L-serine for 5 h, were incubated for 5 min with 2 M 4-amino-5-methylamino-2Ј7Ј-difluorofluorescein diacetate (DAF-FM DA; Invitrogen), a specific dye that emits fluorescence intracellularly only upon interaction with NO. The cells were then gently washed with fresh media and subjected to immunofluorescence microscopy with excitation wavelength at 495 nm and emission wavelength at 515 nm for 15 min with continuous signal recording. For measurements from mouse tissue, brains were sliced into 300 m sections using a McIlwain Tissue Chopper and equilibrated with 95% oxygen/5% CO 2 at 37°C for 30 min in pre-oxygenated artificial CSF (ACSF) buffer containing (in mM) 125 NaCl, 3 KCl, 1.6 CaCl 2 , 0.2 arginine, 25 HEPES, pH 7.4, 11 D-glucose, and 1.25 Na 2 HPO 4 . The slices were then incubated with 0.2 mM DAF-FM DA at 37°C for 1 h, following which they were mechanically lysed and centrifuged at 14,000 rpm for 10 min, and the protein concentration was measured with the BioRad protein assay solution. Lysate (0.25 mg of protein), reconstituted in 1 ml of 20 mM ACSF buffer at pH 7.4,wasthensubjectedtofluorescencemeasurementstodetectNOgenerationas above.
S-nitrosylation biotin switch assay. The assay was carried-out as described previously (Jaffrey and Snyder, 2001 ) but with minor modifications. Briefly, brain tissue from wild-type, SR Ϫ/Ϫ , and nNOS Ϫ/Ϫ mice was homogenized in HEN buffer (250 mM HEPES-NaOH, pH 7.7, 1 mM EDTA, 0.1 mM Neocuproine) supplemented with 100 M deferoxamine (DFO) and centrifuged at 13,000 ϫ g for 20 min at 4°C. Lysate (0.24 mg of protein) was added to blocking buffer [HEN buffer plus 25% SDS and 20 mM methymethanethiosulfonate (MMTS)] at 50°C for 20 min with frequent vortexing. The MMTS was then removed by acetone and the proteins precipitated at Ϫ20°C for 20 min. After acetone removal, the proteins were resuspended in HENS buffer (HEN ϩ 1% SDS). To the suspension was added 1 mM N-͓6-(biotinamido)hexyl͔-3Ј-(2Ј-pyridyldithio)-propionamide (biotin-HPDP) in DMSO with 1 mM ascorbic acid. After incubation for 2 h at 25°C, biotinylated proteins were precipitated by streptavidin-agarose beads that were then washed with HENS buffer. The biotinylated proteins were eluted by SDS-PAGE sample buffer and subjected to Western blot analysis. For quantitation of protein S-nitrosylation, the signals were densitometrically analyzed using the software EagleSight 3.2 (Stratagene) and Odyssey 2.1 (Li-Cor).
Cell culture. Cortical neuronal cultures were obtained as described previously (Kartvelishvily et al., 2006) .
L-Serine measurements. L-Serine from wild-type and SR Ϫ/Ϫ cortical neuronal cultures, treated with 10 mM L-serine for 5 h, was measured as described earlier (Kartvelishvily et al., 2006) . 
Results

Diminished neurotoxicity in SR
؊/؊ cerebral cortical cultures In SR Ϫ/Ϫ cerebral cortical cultures, D-serine levels are reduced ϳ90%, resembling findings in intact mouse brain (Basu et al., 2009) . NO generation by the SR Ϫ/Ϫ cultures is diminished by ϳ50% despite no change in nNOS protein levels ( Fig. 1 A, B) . Oxygen-glucose deprivation neurotoxicity is ϳ50% lower in SR Ϫ/Ϫ cultures as monitored by propidium staining (Fig. 1C,D) .
NO generation and protein S-nitrosylation are reduced in SR ؊/؊ brains We examined the disposition of NO signaling and neurotoxicity in intact animals. NO generation is 70% lower in whole brain of SR Ϫ/Ϫ animals compared with a 95% reduction in nNOS Ϫ/Ϫ animals ( Fig. 2 A) . NO signals in major part by S-nitrosylating a variety of protein targets (Hess et al., 2005) . The diminished NO levels are accompanied by reductions in nitrosylation of ϳ90%, 70%, and 75% of the NO targets ␤-tubulin, GAPDH, and the NR1 subunit of NMDA receptors, respectively (Fig. 2B,C) , extending our preliminary observations of reduced ␤-tubulin and GAPDH nitrosylation in SR Ϫ/Ϫ mice (Basu et al., 2009 ). This profound reduction in nitrosylation emphasizes the intimate linkage of D-serine-associated NMDA neurotransmission with NO signaling.
SR deletion protects against focal cerebral ischemia
We monitored stroke by assessing infarct volume following transient MCA occlusion (MCAO) (Fig. 3A,B) . In SR Ϫ/Ϫ animals, infarct volume is reduced by 50 -60% in cerebral cortex, caudate-putamen, and cerebral hemisphere. The lesser neurotoxicity of brain cultures and diminished MCAO damage in SR mutants fits with diminished NMDA neurotransmission.
SR
؊/؊ mice display NMDA receptor supersensitivity Neurotransmitter deficiency is often associated with receptor supersensitivity that may be manifested in increased levels of receptor protein, as exemplified for dopamine receptors (Kostrzewa et al., 2008) . Because of the extremely high levels of endogenous glutamate derived from multiple sources, relationships of glutamate deficit to receptor sensitivity have not been readily studied. Nonetheless, a study by Nong et al. (2003) demonstrate that the concurrent binding of D-serine (or glycine) and glutamate prime NMDA receptor internalization. It is therefore conceivable that in the absence of D-serine, surface expression of NMDA receptors will likely be increased, leading to receptor supersensitivity. In our earlier study of SR deleted mice, neurophysiologic experiments revealed supersensitivity of NMDA neurotransmission and LTP to D-serine stimulation (Basu et al., 2009) . In SR Ϫ/Ϫ corpus striatum, we observe a fourfold increase in levels of NR1 NMDA receptor protein with no change in NR2 protein (Fig. 4A) . To assess the functional consequences of increased receptor number, we injected NMDA directly into the striatum of SR Ϫ/Ϫ animals and detected a 50% augmentation in NMDA-elicited lesion volume (Fig.  4B,C) .
Discussion
In summary, our study of SR-deleted mice reveals a major regulatory influence of SR-generated D-serine upon NO disposition and neurotoxicity. The pronounced decline of NO formation and nitrosylation of its targets in the mutant mice indicates a greater dependence of NO disposition upon D-serine-associated NMDA neurotransmission than has been previously appreciated. Abundant evidence has implicated overproduction of NO in neurotoxicity, although under some circumstances NO may be neuroprotective (Hara and Snyder, 2007) .
The marked reduction in infarct volume of SR Ϫ/Ϫ animals following MCAO is comparable to protection against stroke damage associated with pharmacologic blockade of NMDA receptors (Lipton, 2006) . NMDA receptor antagonists, however, elicit adverse effects that have precluded clinical application in stroke therapy (Vallance and Leiper, 2002; Lipton, 2006) . Conceivably, selective inhibition of D-serine formation by SR inhibitors would diminish acute stroke damage with fewer undesirable effects. Thus, SR deleted mice appear generally healthy with minimal neurocognitive abnormalities (Basu et al., 2009) , whereas complete genetic deletion of NMDA receptors is lethal (Mohn et al., 1999) .
Because of the difficulties in manipulating glutamate levels, their influences upon NMDA receptor supersensitivity have not been examined in depth. Our findings of a 400% increase in numbers of NR1 subunits in SR Ϫ/Ϫ mice associated with increased NMDA-elicited brain damage provides evidence that receptor occupancy by D-serine is an important determinant of receptor sensitivity. Recently, Inoue et al. (2008) reported no alterations in NR1 levels in the cortex of SR Ϫ/Ϫ animals and 40% decrease in cortical damage following NMDA injections. Reasons for the discrepancies between these findings and ours may reflect a variety of factors, including their use of the cerebral cortex 24 h following NMDA injection and our use of the striatum 48 h following NMDA injection as well as differences in NMDA dose.
It is striking that SR Ϫ/Ϫ mice display less stroke damage despite increased NMDA receptor sensitivity. Presumably with MCAO, levels of D-serine are rate limiting so that the increased glutamate release associated with MCAO is less capable of overstimulating receptors. Direct injections of NMDA may expose receptors to overwhelming stimulation. Moreover, needle damage may lead to substantial release of endogenous glycine, which compensates for the loss of D-serine.
